Group 1 - The core point of the announcement is the election of the fifth board of directors for Chengdu Saintno Biological Technology Co., Ltd., which will consist of 9 members, including 6 non-independent directors and 3 independent directors [1][2] - The board has proposed candidates for the fifth board, including Mr. Wen Yongjun, Ms. Wang Xiaoli, Mr. Yu Xiaohai, Mr. Wu Li, Mr. Yang Guanglin, and Mr. Zeng Dezhi as non-independent directors, and Mr. Xu Zhengsong, Ms. Liu Xia, and Mr. He Zekai as independent directors [1][2] - The election will be conducted at the first extraordinary shareholders' meeting of 2025, using a cumulative voting system, and the independent directors' qualifications must be approved by the Shanghai Stock Exchange before the meeting [2][3] Group 2 - The candidates for the fifth board meet the qualifications required by relevant laws and regulations, and none of them are disqualified from serving as directors [3][5][6] - The current board has been diligent and has contributed positively to the company's operations and development [3] - The fifth board will assume office upon approval at the shareholders' meeting, with a term of three years [2][3] Group 3 - The first extraordinary shareholders' meeting of 2025 is scheduled for December 17, 2025, and will utilize the Shanghai Stock Exchange's online voting system [17][18] - The meeting will combine on-site and online voting methods, with specific time slots for voting [19][20] - Shareholders must register to attend the meeting, and detailed registration procedures are provided [24][25]
成都圣诺生物科技股份有限公司关于董事会换届选举的公告